Stem cells: An overview of the current status of therapies for central and peripheral nervous system diseases

Current Medicinal Chemistry

Volumn 17, Issue 7, 2010, Pages 595-608

  Orlacchio, A ^a,b,c   Bernardi, G ^a,b   Martino, S ^c  

^a IRCCS FONDAZIONE SANTA LUCIA   (Italy)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

^c UNIVERSITY OF PERUGIA   (Italy)

Author keywords

Adult stem cells; Central and peripheral nervous system diseases; Embryonic stem cells; Induced pluripotent stem cells; Stem cell therapy

Indexed keywords

CENTRAL NERVOUS SYSTEM DISEASE; DEMYELINATING DISEASE; FIBROBLAST; HUMAN; NONHUMAN; PARKINSON DISEASE; PERIPHERAL NEUROPATHY; PLURIPOTENT STEM CELL; REVIEW; SPINAL CORD INJURY; STEM CELL TRANSPLANTATION; TRAUMATIC BRAIN INJURY;

ADULT STEM CELLS; EMBRYONIC STEM CELLS; HUMANS; INDUCED PLURIPOTENT STEM CELLS; NEURODEGENERATIVE DISEASES; PERIPHERAL NERVOUS SYSTEM DISEASES; STEM CELL TRANSPLANTATION; STEM CELLS;

EID: 77950653264     PISSN: 09298673     EISSN: None     Source Type: Journal    
DOI: 10.2174/092986710790416272     Document Type: Review

References (193)

1. Lindvall, O.; Kokaia, Z.; Martinez-Serrano, A. Stem cell therapy for human neurodegenerative disorders-how to make it work. Nat. Med., 2004, 10, S42-S50. (Pubitemid 38901866)
2. Alvarez, A.; Unda, F.; Cañavate, M. L.; Hilario, E. Stem cell and regenerative medicine. Curr. Stem Cell Res. Ther., 2009, Dec 1.
3. Gazit, R.; Weissman, I. L.; Rossi, D. J. Hematopoietic stem cells and the aging hematopoietic system. Semin. Hematol., 2008, 45, 218-224.
4. Ma D. K.; Bonaguidi, M. A.; Ming, G. L.; Song, H. Adult neural stem cells in the mammalian central nervous system. Cell Res., 2009, 19, 672-682.
5. Galli, R.; Gritti, A.; Vescovi, A. L. Adult neural stem cells. Methods Mol. Biol., 2008, 438, 67-84.
6. Lee, P. H.; Park, H. J. Bone marrow-derived mesenchymal stem cell therapy as a candidate disease-modifying strategy in Parkinson's disease and multiple system atrophy. J. Clin. Neurol., 2009, 5, 1-10.
7. Uccelli, A.; Moretta, L.; Pistoia, V. Mesenchymal stem cells in health and disease. Nat. Rev. Immunol., 2008, 8, 726-736.
8. Lasky, J. L. 3rd.; Choe, M. N. Cancer Stem Cells in Pediatric Brain Tumors. Curr. Stem Cell Res. Ther., 2009, (epub ahead of print).
9. Woodward, W. A.; Chen, M. S.; Behbod, F.; Rosen, J. M. On mammary stem cells. J. Cell. Sci., 2005, 118, 3585-3594.
10. Mimeault, M.; Batra, S. K. Concise Review: Recent advances on the significance of stem cells in tissue regeneration and cancer therapies. Stem Cells, 2006, 24, 2319-2345.
11. Goldman, S. Stem and progenitor cell-based therapy of the human central nervous system. Nat. Biotechnol., 2005, 23, 862-871. (Pubitemid 43093130)
12. Baker, M. Stem cells: Fast and furious. Nature, 2009, 458, 962-965.
13. Park, D. H.; Eve, D. J.; Borlongan, C. V.; Klasko, S. K.; Cruz, L. E.; Sanberg, P. R. From the basics to application of cell therapy, a steppingstone to the conquest of neurodegeneration: a meeting report. Med. Sci. Monit., 2009, 15, 23-31.
14. Michel, F.; Lévesque, T. N.; Rezak, M. Therapeutic microinjection of autologous adult human neural stem cells and differentiated neurons for Parkinson's disease: Five-Year post-operative outcome. The Open Stem Cell Journal, 2009, 1, 20-29.
15. Bambakidis, N. C.; Miller, R. H. Transplantation of oligodendrocyte precursors and sonic hedgehog results in improved function and white matter sparing in the spinal cords of adult rats after contusion. Spine J., 2004, 4, 16-26.
16. Yamashita, Y. M. The centrosome and asymmetric cell division. Prion, 2009, 3, 84-88.
17. Cheng, J.; Türkel, N.; Hemati, N.; Fuller, M. T.; Hunt, A. J.; Yamashita, Y. M. Centrosome misorientation reduces stem cell division during ageing. Nature, 2008, 456, 599-604.
18. Yamashita, Y. M.; Fuller, M. T.; Jones, D. L. Signaling in stem cell niches: lessons from the Drosophila germline. J. Cell. Sci., 2005, 118, 665-672.
19. Tulina, N.; Matunis, E. Control of stem cell self-renewal in Drosophila spermatogenesis by JAK-STAT signaling. Science, 2001, 294, 2546-2549. (Pubitemid 34027294)
20. Yamashita, Y. M.; Fuller, M. T. Asymmetric centrosome behavior and the mechanisms of stem cell division. J. Cell. Biol., 2008, 180, 261-266. (Pubitemid 351185912)
21. Rusan, N. M.; Peifer, M. A role for a novel centrosome cycle in asymmetric cell division. J. Cell. Biol., 2007, 177, 13-20. (Pubitemid 46588397)
22. Cowan, C. R.; Hyman, A. A. Asymmetric cell division in C. elegans: cortical polarity and spindle positioning. Annu. Rev. Cell Dev. Biol., 2004, 20, 427-453. (Pubitemid 39488645)
23. Gaziova, I.; Bhat, K. M. Generating asymmetry: with and without self-renewal. Prog. Mol. Subcell. Biol., 2007, 45, 143-178.
24. Segalen, M.; Bellaïche, Y. Cell division orientation and planar cell polarity pathways. Semin. Cell Dev. Biol., 2009, (epub ahead of print).
25. Yamashita, Y. M.; Mahowald, A. P.; Perlin, J. R.; Fuller, M. T. Asymmetric inheritance of mother versus daughter centrosome in stem cell division. Science, 2007, 315, 518-521.
26. Kochegarov, A. Small molecules for stem cells. Expert Opin. Ther. Pat., 2009, 19, 275-281.
27. Tsiftsoglou, A. S.; Bonovolias, I. D.; Tsiftsoglou, S. A. Multilevel targeting of hematopoietic stem cell self-renewal, differentiation and apoptosis for leukemia therapy. Pharmacol. Ther., 2009, 122, 264-280.
28. Fleming, H. E.; Janzen, V.; Lo Celso, C.; Guo, J.; Leahy, K. M.; Kronenberg, H. M.; Scadden, D. T. Wnt signaling in the niche enforces hematopoietic stem cell quiescence and is necessary to preserve self-renewal in vivo. Cell Stem Cell, 2008, 2, 274-283.
29. Zardawi, S. J.; O'Toole, S. A.; Sutherland, R. L.; Musgrove, E. A. Dysregulation of Hedgehog, Wnt and Notch signalling pathways in breast cancer. Histol. Histopathol., 2009, 24, 385-398.
30. Angers, S.; Moon, R. T. Proximal events in Wnt signal transduction. Nat. Rev. Mol. Cell Biol., 2009, 10, 468-477.
31. Kikuchi, A.; Yamamoto, H.; Kishida, S. Multiplicity of the interactions of Wnt proteins and their receptors. Cell. Signal., 2007, 19, 659-671. (Pubitemid 46275377)
32. Clevers, H. Wnt/beta-catenin signaling in development and disease. Cell, 2006, 127, 469-480.
33. Hendrickx, M.; Leyns, L. Non-conventional Frizzled ligands and Wnt receptors. Dev. Growth Differ., 2008, 50, 229-243. (Pubitemid 351661159)
34. Adachi, K.; Mirzadeh, Z.; Sakaguchi, M.; Yamashita, T.; Nikolcheva, T.; Gotoh ,Y.; Peltz, G.; Gong, L.; Kawase, T.; Alvarez-Buylla, A.; Okano, H.; Sawamoto, K. Beta-catenin signaling promotes proliferation of progenitor cells in the adult mouse subventricular zone. Stem Cells, 2007, 25, 2827-2836. (Pubitemid 350127867)
35. Borggrefe, T.; Oswald, F. The Notch signaling pathway: Transcriptional regulation at Notch target genes. Cell. Mol. Life Sci., 2009, 66, 1631-1646.
36. Tien, A. C.; Rajan, A.; Bellen, H. J. A Notch updated. J. Cell Biol., 2009, 184, 621-629.
37. Cau, E.; Blader, P. Notch activity in the nervous system: to switch or not switch? Neural Dev., 2009, 4, 36.
38. Ischenko, I.; Seeliger, H.; Schaffer, M.; Jauch, K. W.; Bruns, C. J. Cancer stem cells: how can we target them? Curr. Med. Chem., 2008, 15, 3171-3184.
39. De Felici, M.; Farini, D.; Dolci, S. In or out stemness: comparing growth factor signalling in mouse embryonic stem cells and primordial germ cells. Curr. Stem Cell Res. Ther., 2009, 4, 87-97.
40. Klocke, R.; Kuhlmann, M. T.; Scobioala, S.; Schäbitz, W. R.; Nikol, S. Granulocyte colony-stimulating factor (G-CSF) for cardio-and cerebrovascular regenerative applications. Curr. Med. Chem., 2008, 15, 968-977. (Pubitemid 351736399)
41. Judson, R. L.; Babiarz, J. E.; Venere, M.; Blelloch, R. Embryonic stem cell-specific microRNAs promote induced pluripotency. Nat. Biotechnol., 2009, 27, 459-461.
42. Li, Q.; Gregory, R. I. MicroRNA Regulation of Stem Cell Fate. Cell Stem Cell, 2008, 2, 195-196. (Pubitemid 351298599)
43. Chen, J. F.; Mandel, E. M.; Thomson, J. M.; Wu, Q.; Callis T. E.; Hammond, S. M.; Conlon, F. L.; Wang, D. Z. The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation. Nat. Genet., 2006, 38, 228-233. (Pubitemid 43177239)
44. Landgraf, P.; Rusu, M.; Sheridan, R.; Sewer, A.; Iovino, N.; Aravin, A.; Pfeffer, S.; Rice, A.; Kamphorst, A. O.; Landthaler M. A mammalian microRNA expression atlas based on small RNA library sequencing. Cell, 2007, 129, 1401-1414. (Pubitemid 46970709)
45. Ivey, K. N.; Muth, A.; Arnold, J.; King, F. W.; Yeh, R.; Fish, J. E.; Hsiao, E. C.; Schwartz, R. J.; Conklin, B. R.; Bernstein, H. S.; Srivastava, D. MicroRNA Regulation of Cell Lineages in Mouse and Human Embryonic Stem Cells. Cell Stem Cell, 2008, 2, 219-229. (Pubitemid 351298595)
46. Visvanathan, J.; Lee, B.; Lee, J. W.; Lee, S. K. The microRNA miR-124 antagonizes the anti-neural S. REST/SCP1 pathway during embryonic CNS development. Genes Dev., 2007, 21, 744-749.
47. Cao, X.; Yeo, G.; Muotri, A. R.; Kuwabara, T.; Gage, F. H. Noncoding RNAs in the mammalian central nervous system. Annu. Rev. Neurosci., 2006, 29, 77-103. (Pubitemid 44476840)
48. Wang, Y.; Keys, D. N.; Au-Young, J. K.; Chen, C. MicroRNAs in embryonic stem cells. J. Cell. Physiol., 2009, 218, 251-255.
49. Martino, S.; Di Girolamo, I.; Orlacchio, A.; Datti, A.; Orlacchio, A. MicroRNA implications across neurodevelopment and neuropathology. J. Biomed. Biotechnol., 2009, Oct 13.
50. Trounson, A. The production and directed differentiation of human embryonic stem cells. Endocr. Rev., 2006, 27, 208-219.
51. Unger, C.; Skottman, H.; Blomberg, P.; Dilber, M. S.; Hovatta, O. Good manufacturing practice and clinical-grade human embryonic stem cell lines. Hum. Mol. Genet., 2008, 17, 48-53.
52. Richards, M.; Tan, S. P.; Tan, J. H. The transcriptome profile of human embryonic stem cells as defined by SAGE. Stem Cells, 2004, 22, 51-64. (Pubitemid 38018781)
53. Reubinoff, B. E.; Pera, M. F.; Fong, C. Y.; Trounson, A.; Bongso, A. Embryonic stem cell lines from human blastocysts: somatic differentiation in vitro. Nat. Biotechnol., 2000, 18, 399-404. (Pubitemid 30217526)
54. Chambers, I.; Smith, A. Self-renewal of teratocarcinoma and embryonic stem cells. Oncogene, 2004, 23, 7150-7160. (Pubitemid 39382149)
55. Mitsui, K.; Tokuzawa, Y.; Itoh, H.; Segawa, K.; Murakami, M.; Takahashi, K.; Maruyama, M.; Maeda M.; Yamanaka, S. The homeoprotein Nanog is required for maintenance of pluripotency in mouse epiblast and ES cells. Cell, 2003, 113, 631-641. (Pubitemid 36694188)
56. Rodolfa, K. T.; Eggan, K. Transcriptional Logic for Nuclear Reprogramming. Cell, 2006, 126, 652-655.
57. Yao, S.; Chen, S.; Clark, J.; Hao, E. I; Beattie, G. M.; Hayek, A.; Ding, S. Long-term self-renewal and directed differentiation of human embryonic stem cells in chemically defined conditions. Proc. Natl. Acad. Sci. U. S. A., 2006, 103, 6907-6912.
58. Benetti, R.; Gonzalo, S.; Jaco, I.; Muñoz, P.; Gonzalez, S.; Schoeftner, S.; Murchison, E.; Andl, T.; Chen, T.; Klatt, P.; Li, E.; Serrano, M.; Millar, S.; Hannon, G.; Blasco, M. A. A mammalian microRNA cluster controls DNA methylation and telomere recombination via Rbl2-dependent regulation of DNA methyltransferases. Nat. Struct. Mol. Biol., 2008, 15, 998.
59. Bibikova, M.; Fan, J. B. GoldenGate assay for DNA methylation profiling. Methods Mol. Biol., 2009, 507, 149-163.
60. Sinkkonen, L.; Hugenschmidt, T.; Berninger, P.; Gaidatzis, D.; Mohn, F.; Artus-Revel, C. G.; Zavolan, M.; Svoboda, P.; Filipowicz, W. MicroRNAs control de novo DNA methylation through regulation of transcriptional repressors in mouse embryonic stem cells. Nat. Struct. Mol. Biol., 2008, 15, 259-267. (Pubitemid 351654045)
61. Bernstein, E.; Kim, S. Y.; Carmell, M. A.; Murchison, E. P.; Alcorn, H.; Li, M. Z. Dicer is essential for mouse development. Nat. Genet., 2003, 35, 215-217.
62. Murchison, E. P.; Partridge, J. F.; Tam, O. H.; Cheloufi, S.; Hannon, G. J. Characterization of Dicerdeficient murine embryonic stem cells. Proc. Natl. Acad. Sci. U. S. A., 2005, 102, 12135-12140. (Pubitemid 41291141)
63. Wang, Y.; Medvid, R.; Melton, C.; Jaenisch, R.; Blelloch, R. DGCR8 is essential for microRNAbiogenesis and silencing of embryonic stem cell self-renewal. Nat. Genet., 2007, 39, 380-385. (Pubitemid 46328490)
64. Houbaviy, H. B.; Murray, M. F.; Sharp, P. A. Embryonic stem cell-specific microRNAs. Dev. Cell, 2003, 5, 351-363.
65. Tay, Y.; Zhang, J.; Thomson, A. M.; Lim, B.; Rigoutsos, I. MicroRNAs to Nanog, Oct4 and Sox2 coding regions modulate embryonic stem cell differentiation. Nature, 2008, 455, 1124-1128.
66. Brittan, M.; Wright, N. A. Gastrointestinal stem cells. J. Pathol., 2002, 197, 492-509.
67. Tumbar, T.; Guasch, G.; Greco, V.; Blanpain, C.; Lowry, W. E.; Rendl, M.; Fuchs, E. Defining the epithelial stem cell niche in skin. Science, 2004, 303, 359-363. (Pubitemid 38095773)
68. Galli R.; Borello, U.; Gritti, A.; Minasi, M. G.; Bjornson, C.; Coletta, M.; Mora, M.; De Angelis, M. G.; Fiocco, R.; Cossu, G.; Vescovi, A. L. Skeletal myogenic potential of human and mouse neural stem cells. Nat. Neurosci., 2000, 3, 986-991.
69. Kim, C. F.; Jackson, E. L.; Woolfenden, A. E.; Lawrence, S.; Babar. I.; Vogel, S.; Crowley, D.; Bronson, R. T.; Jacks, T. Identification of bronchioalveolar stem cells in normal lung and lung cancer. Cell., 2005, 121, 823-835. (Pubitemid 40806415)
70. Leri, A.; Kajstura, J.; Anversa, P. Cardiac stem cells and mechanisms of myocardial regeneration. Physiol. Rev., 2005, 85, 1373-1416. (Pubitemid 41362274)
71. Suen, P. M.; Leung, P. S. Pancreatic stem cells: A glimmer of hope for diabetes? JOP, 2005, 6, 422-424. (Pubitemid 41574036)
72. Guettier, C. Which stem cells for adult liver? Ann. Pathol., 2005, 25, 33-44. (Pubitemid 40488412)
73. Li, L.; Xie, T. Stem cell niche: Structure and function. Ann. Rev. Cell Dev. Biol., 2005, 21, 605-631. (Pubitemid 41740648)
74. Heissig, B.; Ohki, Y.; Sato, Y.; Rafii, S.; Werb, Z.; Hattori, K. A role for niches in hematopoietic cell development. Hematology, 2005, 10, 247-253. (Pubitemid 41801141)
75. Ortiz-Gonzalez, X. R.; Keene, C. D.; Verfaillie, C. M.; Low, W. C. Neural induction of adult bone marrow and umbilical cord stem cells. Curr. Neurovasc. Res., 2004, 1, 207-213.
76. Rollini, P.; Kaiser, S.; Faes-van't Hull, E.; Kapp, U.; Leyvraz, S. Long-term expansion of transplantable human fetal liver hematopoietic stem cells. Blood., 2004, 103, 1166-1170.
77. Bonner-Weir, S.; Weir, G. C. New sources of pancreatic beta-cells. Nat. Biotechnol., 2005, 23, 857-861.
78. Erices, A. A.; Allers, C. I.; Conget, P. A.; Rojas, C. V.; Minguell, J. J. Human cord blood-derived mesenchymal stem cells home and survive in the marrow of immunodeficient mice after systemic infusion. Cell Transplant., 2003, 12, 555-561.
79. Roche, E.; Reig, J. A.; Campos, A.; Paredes, B.; Isaac, J. R.; Lim, S.; Calne, R. Y.; Soria, B. Insulin-secreting cells derived from stem cells: Clinical perspectives, hypes and hopes. Transpl. Immunol., 2005, 15, 113-129. (Pubitemid 43075332)
80. Yamazaki, S.; Nakauchi, H. Insights into signaling and function of hematopoietic stem cells at the single-cell level. Curr. Opin. Hematol., 2009, 16, 255-258.
81. Pittenger, M. F.; Mackay, A. M.; Beck, S. C.; Jaiswal, R. K.; Douglas, R.; Mosca, J. D.; Moorman, M. A.; Simonetti, D. W.; Craig, S.; Marshak, D. R. Multilineage potential of adult human mesenchymal stem cells. Science, 1999, 284, 143-147. (Pubitemid 29282067)
82. Seaberg, R. M.; Smukler, S. R.; Kieffer, T. J.; Enikolopov, G.; Asghar, Z.; Wheeler, M. B.; Korbutt, G.; Van Der Kooy, D. Clonal identification of multipotent precursors from adult mouse pancreas that generate neural and pancreatic lineages. Nat. Biotechnol., 2004, 22, 1115-1124. (Pubitemid 39166849)
83. Berns, A. Stem cells for lung cancer? Cell, 2005, 121, 811-813. (Pubitemid 40806410)
84. Fuchs, E.; Tumbar, T.; Guasch, G. Socializing with the neighbors: Stem cells and their niche. Cell, 2004, 116, 769-778. (Pubitemid 38410723)
85. McKay, R. D. Stem cell biology and neurodegenerative disease. Phil. Trans. R. Soc. Lond. B. Biol. Sci., 2004, 359, 851-856. (Pubitemid 38673752)
86. Cossu, G.; Bianco, P. Mesoangioblasts-vascular progenitors for extravascular mesodermal tissues. Curr. Opin. Genet. Dev., 2003, 13, 537-542. (Pubitemid 37204932)
87. Baum, C. M.; Weissman, I. L.; Tsukamoto, A. S.; Buckle, A. M.; Peault, B. Isolation of a candidate human hematopoietic stem-cell population. Proc. Natl. Acad. Sci. U. S. A., 1992, 89, 2804-2808.
88. Broxmeyer, H. E.; Douglas, G. W.; Hangoc, G.; Cooper, S.; Bard, J.; English, D.; Arny, M.; Thomas, L.; Boyse, E. A. Human umbilical cord blood as a potential source of transplantable hematopoietic stem/progenitor cells. Proc. Natl. Acad. Sci. U. S. A., 1989, 86, 3828-3832.
89. Ciulla, M. M.; Acquistapace, G.; Toffetti, L.; Magrini, F.; Paliotti, R. Experimental animal models of myocardial damage in regenerative medicine studies involving adult bone marrow derived stem cells: ethical and methodological implications. Card. Hematol. Disord. Drug Targ., 2009, 9, 86-94.
90. Namikawa, R.; Weilbaecher, K. N.; Kaneshima, H.; Yee, E. J.; Mc Cune, J. M. J. Long-term human hematopoiesis in the SCID-hu mouse. Exp. Med., 1990, 172, 1055-1063. (Pubitemid 20343205)
91. Ramiya, V. K.; Maraist, M.; Arfors, K. E.; Schatz, D. A.; Peck, A. B.; Cornelius, J. G. Reversal of insulin-depend-ent diabetes using islets generated in vitro from pancreatic stem cells. Nat. Med., 2000, 6, 278-282.
92. Seale, P.; Sabourin, L. A.; Girgis-Gabardo, A.; Mansouri, A.; Gruss, P.; Rudnicki, M. A. Pax7 is required for the specification of myogenic satellite cells. Cell, 2000, 102, 777-786.
93. Zuk, P. A.; Zhu, M.; Mizuno, H.; Huang, J.; Futrell, J. W.; Katz, A. J.; Benhaim, P.; Lorenz, H. P.; Hedrick, M. H. Multilineage cells from human adipose tissue: implications for cell- based therapies. Tissue Eng., 2001, 7, 211-228.
94. Zulewski, H.; Abraham, E. J.; Gerlach, M. J.; Daniel, P. B.; Moritz, W.; Muller, B.; Vallejo, M.; Thomas, M. K.; Habener, J. F. Multipotential nestin-positive stem cells isolated from adult pancreatic islets differentiate ex vivo into pancreatic endocrine, exocrine, and hepatic phenotypes. Diabetes, 2001, 50, 521-533.
95. Martino, S.; di Girolamo, I.; Tiribuzi, R.; D'Angelo, F.; Datti, A.; Orlacchio, A. Efficient siRNA delivery by the cationic liposome DOTAP in human hematopoietic stem cells differentiating into dendritic cells. J. Biomed. Biotechnol., 2009, (epub ahead of print)..
96. Martino, S.; D'Angelo, F.; Armentano, I.; Tiribuzi, R.; Pennacchi, M.; Dottori, M.; Samantha M.; Caraffa, A.; Cerulli, G. G.; Kenny, J. M.; Orlacchio, A. Hydrogenated amorphous carbon nanopatterned film designs drive human bone marrow mesenchymal stem cell cytoskeleton architecture. Tissue Eng. Part A, 2009, 15, 3139-3149.
97. Hirao, A.; Arai, F.; Suda, T. Regulation of cell cycle in hematopoietic stem cells by the niche. Cell Cycle, 2004, 3, 1481-1483. (Pubitemid 40521394)
98. + hematopoietic stem-progenitor cell microRNA expression and function: a circuit diagram of differentiation control. Proc. Natl. Acad. Sci. U. S. A., 2007, 104, 2750-2755.
99. Cheng, L. C.; Pastrana, E.; Tavazoie, M.; Doetsch, F. miR-124 regulates adult neurogenesis in the subventricular zone stem cell niche. Nat. Neurosci., 2009, 12, 399-408.
100. Takahashi, K.; Yamanaka, S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell, 2006, 126, 663-676. (Pubitemid 44233629)
101. Sendtner, M. Stem cells: Tailor-made diseased neurons. Nature, 2009, 457, 269-270.
102. Judson, R. L; Babiarz, J. E.; Venere, M.; Blelloch, R. Embryonic stem cell-specific microRNAs promote induced pluripotency. Nat. Biotechnol., 2009, 27, 459-461.
103. Woltjen, K.; Michael, I. P.; Mohseni, P.; Desai, R.; Mileikovsky, M.; Hämäläinen, R.; Cowling, R.; Wang, W.; Liu, P.; Gertsenstein, M.; Kaji, K; Sung, H. K.; Nagy, A. piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells. Nature, 2009, 458, 766-770.
104. Kaji, K.; Norrby, K.; Paca, A.; Mileikovsky, M.; Mohseni, P.; Woltjen, K. Virus-free induction of pluripotency and subsequent excision of reprogramming factors. Nature, 2009, 458, 771-775.
105. Karumbayaram, S.; Novitch, B. G.; Patterson, M.; Umbach, J. A.; Richter, L.; Lindgren, A.; Conway, A. E.; Clark, A. T.; Goldman, S. A.; Plath, K.; Wiedau-Pazos, M.; Kornblum, H. I.; Lowry, W. E. Directed differentiation of human-induced pluripotent stem cells generates active motor neurons. Stem Cells, 2009, 27, 806-811.
106. Park, I. H.; Arora, N.; Huo, H.; Maherali, N.; Ahfeldt, T.; Shimamura, A., Lensch, M. W.; Cowan, C.; Hochedlinger, K.; Daley, G. Q. Disease-specific induced pluripotent stem cells. Cell, 2008, 134, 877-886.
107. Soldner, F.; Hockemeyer, D.; Beard, C.; Gao, Q.; Bell, G. W.; Cook, E. G.; Hargus, G.; Blak, A.; Cooper, O.; Mitalipova, M.; Isacson, O.; Jaenisch, R. Parkinson's disease patient-derived induced pluripotent stem cells free of viral reprogramming factors. Cell, 2009, 136, 964-977.
108. Dimos, J. T.; Rodolfa, K. T.; Niakan, K. K.; Weisenthal, L. M.; Mitsumoto, H.; Chung, W.; Croft, G. F.; Saphier, G.; Leibel, R.; Goland, R.; Wichterle, H.; Henderson, C. E.; Eggan, K. Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons. Science, 2008, 321, 1218-1221.
109. Ebert, A. D.; Yu, J.; Rose, F. F. Jr.; Mattis, V. B.; Lorson, C. L.; Thomson, J. A.; Svendsen, C. N. Induced pluripotent stem cells from a spinal muscular atrophy patient. Nature, 2009, 457, 277-280.
110. Baker, M. Stem cells: Fast and furious. Nature, 2009, 458, 962-965.
111. Zhang Z. G.; Chopp, M. Neurorestorative therapies for stroke: underlying mechanisms and translation to the clinic. Lancet Neurol., 2009, 8, 491-500.
112. Beachy, P. A.; Karhadkar, S. S.; Berman, D. M. Tissue repair and stem cell renewal in carcinogenesis. Nature, 2004, 432, 324-331. (Pubitemid 39551660)
113. Boucherie, C.; Hermans, E. Adult stem cell therapies for neurological disorders: Benefits beyond neuronal replacement? J. Neurosci. Res., 2008, 87, 1509-1521.
114. Park, D. H.; Eve, D. J.; Borlongan, C. V.; Klasko, S. K.; Cruz, L. E.; Sanberg, P. R. From the basics to application of cell therapy, a steppingstone to the conquest of neurodegeneration: a meeting report. Med. Sci. Monit., 2009, 15, 23-31.
115. Harris, D. T. Cord blood stem cells: worth the investmen. Nat. Rev. Cancer, 2008, 8, 823.
116. Richardson, R. M.; Larson, P. S.; Bankiewicz, K. S. Gene and cell delivery to the degenerated striatum: status of preclinical efforts in primate models. Neurosurgery, 2008, 63, 629-642.
117. Pahnke, J.; Wolkenhauer, O.; Krohn, M.; Walker, L. C. Clinico-pathologic function of cerebral ABC transporters-implications for the pathogenesis of Alzheimer's disease. Curr. Alzheimer Res., 2008, 5, 396-405.
118. Goedert, M.; Spillantini, M. G. A century of Alzheimer's disease. Science, 2006, 314, 777-781.
119. Ansbury, P. T.; Lashuel, H. A. A century-old debate on protein aggregation and neurodegeneration enters the clinic. Nature, 2006, 443, 774-779.
120. Turner, R. S. Alzheimer's disease. Semin. Neurol., 2006, 26, 499-506.
121. Orlacchio, A.; Bernardi, G.; Orlacchio, A.; Martino, S. Patented therapeutic RNAi strategies for neurodegenerative diseases of the CNS. Expert Opin. Ther. Pat., 2008, 18, 1161-1166.
122. Ohyagi, Y.; Tabira, T. Intracellular amyloid beta-protein and its associated molecole in the pathogenesis of Alzheimer's disease. Mini Rev. Med. Chem., 2006, 6, 1075-1080. (Pubitemid 44524450)
123. Goldgaber, D.; Lerman, M. I.; Mcbride, O. W. Characterization and chromosomal localization of a cDNA encoding brain amyloid of Alzheimer's disease. Science, 1987, 235, 877-880.
124. Orlacchio, A.; Bernardi, G.; Orlacchio, A.; Martino, S. RNA interference as a tool for Alzheimer's disease therapy. Mini Rev. Med. Chem., 2007, 7, 1166-1176. (Pubitemid 350200223)
125. Costanzi, E.; Martino, S.; Persichetti, E.; Tiribuzi, R.; Massini, C.; Bernardi, G.; Orlacchio, A.; Orlacchio, A. Effects of Vitamin C on Fibroblasts from Sporadic Alzheimer's Disease Patients. Neurochem. Res., 2007, 33, 2510-2515.
126. Wu, S.; Sasaki, A.; Yoshimoto, R.; Kawahara, Y.; Manabe, T.; Kataoka, K.; Asashima, M.; Yuge, L. Neural stem cells improve learning and memory in rats with Alzheimer's disease. Pathobiology, 2008, 75, 186-194.
127. Sugaya, K.; Merchant, S. How to approach Alzheimer's disease therapy using stem cell technologies. J. Alzheimers Dis., 2008, 15, 241-254.
128. Waldau, B.; Shetty, A. K. Behavior of neural stem cells in the Alzheimer brain. Cell. Mol. Life Sci., 2008, 65, 2372-2384.
129. Sugaya, K.; Kwak, Y. D.; Ohmitsu, O.; Marutle, A.; Greig, N. H.; Choumrina, E. Practical issues in stem cell therapy for Alzheimer's disease. Curr. Alzheimer Res., 2007, 4, 370-377. (Pubitemid 47416630)
130. Hoehn, M.; Yahr, M. D. Parkinsonism: onset, progression, and mortality. Neurology, 2001, 57, 11-26.
131. Nussbaum, R. L.; Polymeropoulos, M. H. Genetics of Parkinson's disease. Hum. Mol. Genet., 1997, 6, 1687-1691.
132. Polymeropoulos, M. H.; Lavedan, C.; Leroy, E. Genetics of Parkinson's disease. Science, 1997, 276, 2045-2047.
133. Freeman, J. W.; Simmons, M.; Matos, E. Parkinson disease: an incremental challenge. S. D. Medicine, 2007, 60, 481-484.
134. Balducci, C.; Pierguidi, L.; Persichetti, E.; Parnetti, L.; Sbaragli, M.; Tassi, C.; Orlacchio, A.; Calabresi, P.; Beccari, T.; Rossi, A. Lysosomal hydrolases in cerebrospinal fluid from subjects with Parkinson's disease. Mov. Dis., 2007, 22, 1481-1484. (Pubitemid 47280636)
135. Kordower, J. H.; Freeman, T. B.; Snow, B. J.; Vingerhoets, F. J.; Mufson, E. J.; Sanberg, P. R.; Hauser, R. A.; Smith, D. A.; Nauert, G. M.; Perl, D. P.; Olanov, C. W. N. Neuropathological evidence of graft survival and striatal reinnervation after the transplantation of fetal mesencephalic tissue in a patient with Parkinson's Disease. Engl. J. Med., 1995, 332, 1118-1124.
136. Mendez, I.; Sanchez-Pernaute, R.; Cooper, O.; Viñuela, A.; Ferrari, D.; Björklund, L; Dagher, A.; Isacson, O. Cell type analysis of functional fetal dopamine cell suspension transplants in the striatum and substantia nigra of patients with Parkinson's disease. Brain, 2005, 128, 1498-1499. (Pubitemid 41373670)
137. Stamey, W.; Jankovic, J. Impulse control disorders and pathological gambling in patients with Parkinson disease. Neurologist, 2008, 14, 89-99. (Pubitemid 351366941)
138. Newman, M. B.; Bakay, R. A. Therapeutic potentials of human embryonic stem cells in Parkinson's disease. Neurotherapeutics, 2008, 5, 237-251. (Pubitemid 351446218)
139. Goya, R. L.; Kuan, W. L.; Barker, R. A. The future of cell therapies in the treatment of Parkinson's disease. Expert Opin. Biol. Ther., 2007, 7, 1487-1498. (Pubitemid 47597138)
140. Goldman, S. A. Disease targets and strategies for the therapeutic modulation of endogenous neural stem and progenitor cells. Clin. Pharmacol. Ther., 2007, 82, 453-460.
141. Picinich, S. C.; Mishra, P. J.; Mishra, P. J.; Glod, J.; Banerjee, D. The therapeutic potential of mesenchymal stem cells. Cell- & tissue-based therapy. Expert Opin. Biol. Ther., 2007, 7, 965-973.
142. Li, J. Y.; Christophersen, N. S.; Hall, V.; Soulet, D.; Brundin, P. Critical issues of clinical human embryonic stem cell therapy for brain repair. Trends Neurosci., 2008, 31, 146-153.
143. Friling, S.; Andersson. E.; Thompson, L. H.; Jönsson, M. E.; Hebsgaard, J. B.; Nanou, E.; Alekseenko, Z; Marklund, U.; Kjellander, S.; Volakakis, N.; Hovatta, O.; El Manira, A.; Björklund, A.; Perlmann, T.; Ericson, J. Efficient production of mesencephalic dopamine neurons by Lmx1a expression in embryonic stem cells. Proc. Natl. Acad. Sci. U. S. A., 2009, 106, 7613-7618.
144. Madhavan, L.; Daley, B. F.; Paumier, K. L.; Collier, T. J. Transplantation of subventricular zone neural precursors induces an endogenous precursor cell response in a rat model of Parkinson's disease. J. Comp. Neurol., 2009, 515, 102-115.
145. Korecka, J. A.; Verhaagen, J.; Hol, E. M. Cell-replacement and gene-therapy strategies for Parkinson's and Alzheimer's disease. Regen. Med., 2007, 2, 425-446. (Pubitemid 47307222)
146. Isacson, O.; Kordower, J. H. Future of cell and gene therapies for Parkinson's disease. Ann. Neurol., 2008, 64, 122-138.
147. Stack, E. C.; Ferrante, R. J. Huntington's disease: progress and potential in the field. Expert Opin. Investig. Drugs, 2007, 16, 1933-1953.
148. Wild, E. I.; Tabrizi, S. J. Huntington's disease phenocopy syndromes. Curr. Opin. Neurol., 2007, 20, 681-687.
149. Yu, D.; Silva, G. A. Stem cell sources and therapeutic approaches for central nervous system and neural retinal disorders. Neurosurg. Focus, 2008, 24, E11.
150. McBride, J. L.; Behrstock, S. P.; Chen, E. Y.; Jakel , R. J.; Siegel, I.; Svendsen, C. N.; Kordower, J. H. Human neural stem cell transplants improve motor function in a rat model of Huntington's disease. J. Comp. Neurol., 2004, 475, 211-219.
151. Visnyei, K.; Tatsukawa, K. J.; Erickson, R. I.; Simonian, S.; Oknaian, N.; Carmichael, S. T.; Kornblum, H. I. Neural progenitor implantation restores metabolic deficits in the brain following striatal quinolinic acid lesion. Exp. Neurol., 2006, 197, 465-474.
152. Bachoud-Lévi, A. C.; Gaura, V.; Brugières, P.; Lefaucheur, J. P.; Boissé, M. F.; Maison, P.; Baudic, S.; Ribeiro, M. J.; Bourdet, C.; Remy, P.; Cesaro, P.; Hantraye, P.; Peschanski, M. Effect of fetal neural transplants in patients with Huntington's disease 6 years after surgery: a long-term follow-up study. Lancet Neurol., 2006, 5, 303-309.
153. Philpott, L. M.; Kopyov, O. V.; Lee, A. J.; Jacques, S.; Duma, C. M.; Caine, S.; Yang, M.; Eagle, K. S. Neuropsychological functioning following fetal striatal transplantation in Huntington's chorea: three case presentations. Cell Transplant., 1997, 6, 203-212.
154. Vazey, E. M.; Chen, K.; Hughes, S. M.; Connor, B. Transplanted adult neural progenitor cells survive, differentiate and reduce motor function impairment in a rodent model of Huntington's disease. Exp. Neurol., 2006, 199, 384-386. (Pubitemid 43928967)
155. Amin, E. M.; Reza, B. A.; Morteza, B. R.; Maryam, M. M.; Ali, M.; Zeinab, N. Microanatomical evidences for potential of mesenchymal stem cells in amelioration of striatal degeneration. Neurol. Res., 2008, 30, 1086-1090.
156. Yang, C. R.; Yu, R. K. Intracerebral transplantation of neural stem cells combined with trehalose ingestion alleviates pathology in a mouse model of Huntington's disease. J. Neurosci. Res., 2009, 87, 26-33.
157. Wolfson, C.; Kilborn, S.; Oskoui, M.; Genge, A. Incidence and Prevalence of Amyotrophic Lateral Sclerosis in Canada: A Systematic Review of the Literature. Neuroepidemiology, 2009, 33, 79-88.
158. Orlacchio, A.; Bernardi, G.; Orlacchio, A.; Martino, S. Genetics of amyotrophic lateral sclerosis. Rec. Res. Dev. Neurosci., 2007, 17-54.
159. Andrews, J. Amyotrophic lateral sclerosis: clinical management and research update. Curr. Neurol. Neurosci. Rep., 2009, 9, 59-68.
160. Brown, R. H. Jr. Developmental biology. Neuron research leaps ahead. Science, 2008, 321, 1169-1170.
161. Deda, H.; Inci, M. C.; Kürekçi, A. E.; Sav, A.; Kayihan Ozgün, E.; Ustünsoy, G. E.; Kocabay, S. Treatment of amyotrophic lateral sclerosis patients by autologous bone marrow-derived hematopoietic stem cell transplantation: a 1-year follow-up. Cytotherapy, 2009, 11, 18-25.
162. Appel, S. H.; Engelhardt, J. I.; Henkel, J. S.; Siklos, L.; Beers, D. R.; Yen, A. A.; Simpson, E. P.; Luo, Y.; Carrum, G.; Heslop, H. E.; Brenner, M. K.; Popat, U. Hematopoietic stem cell transplantation in patients with sporadic amyotrophic lateral sclerosis. Neurology, 2008, 71, 1326-1334.
163. Zhang, C.; Zhou, C.; Teng, J. J.; Zhao, R. L.; Song, Y. Q. Multiple administrations of human marrow stromal cells through cerebro-spinal fluid prolong survival in a transgenic mouse model of amyotrophic lateral sclerosis. Cytotherapy, 2009, 11, 299-306.
164. Rizvanov, A. A.; Kiyasov, A. P.; Gaziziov, I. M.; Yilmaz, T. S.; Kaligin, M. S.; Andreeva, D. I.; Shafigullina, A. K.; Guseva, D. S.; Kiselev, S. L.; Matin, K.; Palotás, A.; Islamov, R. R. Human umbilical cord blood cells transfected with VEGF and L(1)CAM do not differentiate into neurons but transform into vascular endothelial cells and secrete neuro-trophic factors to support neuro-genesis-a novel approach in stem cell therapy. Neurochem. Int., 2008, 53, 389-394.
165. Morita, E.; Watanabe, Y.; Ishimoto, M.; Nakano, T.; Kitayama, M.; Yasui, K.; Fukada, Y.; Doi, K.; Karunaratne, A.; Murrell, W. G.; Sutharsan, R.; Mackay-Sim, A.; Hata, Y.; Nakashima, K. A novel cell transplantation protocol and its application to an ALS mouse model. Exp. Neurol., 2008, 213, 431-438.
166. Vercelli, A.; Mereuta, O. M.; Garbossa, D.; Muraca, G.; Mareschi, K.; Rustichelli, D.; Ferrero, I.; Mazzini, L.; Madon, E., Fagioli, F. Human mesenchymal stem cell transplantation extends survival, improves motor
167. Obermair, F. J.; Schröter, A.; Thallmair, M. Endogenous neural progenitor cells as therapeutic target after spinal cord injury. Physiology, 2008, 23, 296-304.
168. Barnabé-Heider, F.; Frisén, J. Stem cells for spinal cord repair. Cell Stem Cell, 2008, 3, 16-24.
169. Bambakidis, N. C.; Miller, R. H. Transplantation of oligodendrocyte precursors and sonic hedgehog results in improved function and white matter sparing in the spinal cords of adult rats after contusion. Spine J., 2004, 4, 16-26.
170. Matsuda, R.; Yoshikawa, M.; Kimura, H.; Ouji, Y.; Nakase, H.; Nishimura, F.; Nonaka, J.; Toriumi, H.; Yamada, S.; Nishiofuku, M.; Moriya, K.; Ishizaka, S.; Nakamura, M.; Sakaki, T. Cotransplantation of mouse embryonic stem cells and bone marrow stromal cells following spinal cord injury suppresses tumor development. Cell Transplant., 2009, 18, 39-54.
171. Zhang, L.; Zhang, H. T.; Hong, S. Q.; Ma, X.; Jiang, X. D.; Xu, R. X. Cografted Wharton's Jelly Cells-derived Neurospheres and BDNF Promote Functional Recovery After Rat Spinal Cord Transection. Neurochem. Res., 2009, 34, 2030-2039.
172. Paul, C.; Samdani, A. F.; Betz, R. R.; Fischer, I.; Neuhuber, B. Grafting of human bone marrow stromal cells into spinal cord injury: a comparison of delivery methods. Spine, 2009, 34, 328-334.
173. Akesson, E.; Sandelin, M.; Kanaykina, N.; Aldskogius, H.; Kozlova, E. N. Long-term survival, robust neuronal differentiation, and extensive migration of human forebrain stem/progenitor cells transplanted to the adult rat dorsal root ganglion cavity. Cell Transplant., 2008, 17, 1115-1123.
174. Montes, J.; Gordon, A. M.; Pandya, S.; De Vivo, D. C.; Kaufmann, P. Clinical outcome measures in spinal muscular atrophy. J. Child Neurol., 2009, Jun 9.
175. Suzuki, K.; Kastuno, M.; Banno, H.; Sobue, G. Pathogenesis-targeting therapeutics for spinal and bulbar muscular atrophy (SBMA). Neuropathology, 2009, 29, 509-516.
176. Clermont, O.; Burlet, P.; Lefebvre, S; Bürglen, L.; Munnich, A.; Melki, J. SMN gene deletions in adult-onset spinal muscular atrophy. Lancet, 1995, 346, 8991-8992.
177. Lefebvre, S.; Burlet, P.; Liu, Q.; Bertrandy, S.; Clermont, O.; Munnich, A.; Dreyfuss, G.; Melki, J. Correlation between severity and SMN protein level in spinal muscular atrophy. Nat. Genet., 1997, 16, 265-269. (Pubitemid 27280210)
178. Mattis, V. B.; Butchbach, M. E.; Lorson, C. L. Detection of human survival motor neuron (SMN) protein in mice containing the SMN2 transgene: applicability to preclinical therapy development for spinal muscular atrophy. J. Neurosci. Methods, 2008, 175, 36-43.
179. Corti, S.; Nizzardo, M.; Nardini, M.; Donadoni, C.; Salani, S.; Ronchi, D.; Saladino, F.; Bordoni, A.; Fortunato, F.; Del Bo, R. Neural stem cell transplantation can ameliorate the phenotype of a mouse model of spinal muscular atrophy. J. Clin. Invest., 2008, 118, 3316-3330.
180. Begley, D. J.; Pontikis, C. C.; Scarpa, M. Lysosomal storage diseases and the blood-brain barrier. Curr. Pharm. Des., 2008, 14, 1566-1580. (Pubitemid 352002984)
181. Goldman, S. A.; Schanz, S.; Windrem. M. S. Stem cell-based strategies for treating pediatric disorders of myelin. Hum. Mol. Genet., 2008, 17, 76-83.
182. Enns, G. M.; Huhn, S. L. Central nervous system therapy for lysosomal storage disorders. Neurosurg. Focus, 2008, 24, E12.
183. Pan, T.; Kondo, S.; Le, W.; Jankovic, J. The role of autophagy-lysosome pathway in neurodegeneration associated with Parkinson's disease. Brain, 2008, 131, 1969-1978.
184. Biffi, A.; Lucchini, G.; Rovelli, A.; Sessa, M. Metachromatic leukodystrophy: an overview of current and prospective treatments. Bone Marrow Transplant., 2008, 42, 2-6.
185. Tokimasa, S.; Ohta, H.; Takizawa, S.; Kusuki, S.; Hashii, Y.; Sakai, N.; Taniike, M.; Ozono, K.; Hara, J. Umbilical cord-blood transplantations from unrelated donors in patients with inherited metabolic diseases: Single-institute experience. Pediatr. Transplant., 2008, 12, 672-676.
186. Pierret, C.; Morrison, J. A.; Kirk, M. D. Treatment of lysosomal storage disorders: focus on the neuronal ceroid-lipofuscinoses. Acta Neurobiol. Exp., 2008, 68, 429-442.
187. Lee, J. P.; Jeyakumar, M.; Gonzalez, R.; Takahashi, H.; Lee, P. J.; Baek, R. C.; Clark, D.; Rose, H.; Fu, G.; Clarke, J., McKercher, S.; Meerloo, J.; Muller, F. J., Park, K. I.; Butters, T. D., Dwek, R. A.; Schwartz, P.; Tong, G.; Wenger, D.; Lipton, S. A.; Seyfried, T. N.; Platt, F. M., Snyder, E. Y. Stem cells act through multiple mechanisms to benefit mice with neurodegenerative metabolic disease. Nat. Med., 2007, 13, 439-447. (Pubitemid 46559825)
188. Martino,S.; Emiliani, C.; Tancini, B.; Severini, G. M.; Chigorno, V.; Bordignon, C.; Sonnino, S.; Orlacchio A. Absence of metabolic cross-correction in Tay-Sachs cells: implication in gene therapy. J. Biol. Chem., 2002, 277, 20177-20184. (Pubitemid 34967309)
189. Martino, S.; Cavalieri, C.; Emiliani, C.; Dolcetta, D.; Cusella De Angelis, M. G.; Chigorno, V.; Severini, G. M.; Sandhoff, K.; Bordignon, C.; Sonnino, S.; Orlacchio, A. Restoration of GM2 ganglioside metabolism in bone marrow-derived stromal cells from Tay Sachs disease animal model. Neurochem. Res., 2002, 27, 793-800.
190. Arfi, A.; Bourgoin, C.; Basso, L.; Emiliani, C.; Tancini, B.; Chigorno, V.; Li, Y. T.; Orlacchio, A.; Poenaru, L.; Sonnino, S.; Caillaud, C. Bicistronic lentiviral vector corrects beta-hexosaminidase defi ciency in transduced and cross-corrected human Sandhoff fibroblasts. Neurobiol. Dis., 2005, 20, 583-593. (Pubitemid 41476284)
191. Martino, S.; Marconi, P.; Tancini, B.; Dolcetta, D.; De Angelis, M. G.; Montanucci, P.; Bregola, G.; Sandhoff, K.; Bordignon, C.; Emiliani, C.; Manservigi, R.; Orlacchio, A. A direct gene transfer strategy via brain internal capsule reverses the biochemical defect in Tay-Sachs disease. Hum. Mol. Gen., 2005, 14, 2113-2123. (Pubitemid 41418011)
192. Martino, S.; di Girolamo, I.; Cavazzin, C.; Tiribuzi, R.; Galli, R.; Rivaroli, A.; Valsecchi, M.; Sandhoff, K.; Sonnino, S.; Vescovi, A.; Gritti, A.; Orlacchio, A. Neural precursor cell cultures from GM2 gangliosidosis animal models recapitulate the biochemical and molecular hallmarks of the brain pathology. J. Neurochem., 2009, 109, 135-147.
193. Rosenthal, N. Youthful prospects for human stem-cell therapy. EMBO Rep., 2005, 6, S30-S34. (Pubitemid 44269465)